首页 > 最新文献

Experimental and clinical psychopharmacology最新文献

英文 中文
Expectancy of alcohol analgesia moderates perception of pain relief following acute alcohol intake. 对酒精镇痛的期望调节急性酒精摄入后疼痛缓解的感觉。
IF 2.3 3区 医学 Q2 Medicine Pub Date : 2024-04-01 Epub Date: 2023-06-26 DOI: 10.1037/pha0000664
Casey Alexander, Nicholas J Bush, John K Neubert, Michael Robinson, Jeff Boissoneault

Although laboratory studies indicate alcohol reduces pain intensity and increases pain threshold, these effects likely do not completely explain perceived pain relief from alcohol intake. In this study, we tested expectancy of alcohol analgesia (EAA) as a moderator of subjective pain relief following oral alcohol challenge in individuals with and without chronic orofacial pain. Social drinkers (N = 48; 19 chronic pain; 29 pain-free controls) completed two testing sessions: alcohol administration (BrAC: 0.08 g/dL) and placebo. Alcohol expectancy (AE) was assessed using the EAA questionnaire and two 100-mm Visual Analogue Scales (VASs) regarding strength of belief that alcohol provides pain relief (AE VAS 1) or reduces pain sensitivity (AE VAS 2). Participants completed quantitative sensory testing (QST) involving application of pressure to the masseter insertion. Pain threshold (lbf; three repetitions) and pain intensity (4, 5, and 6 lbf; three repetitions each; 100-mm VAS) were collected. After each stimulus, participants rated perceived pain relief due to consumption of the study beverage (0-100 VAS). Higher EAA and AE VAS 1 ratings were associated with stronger perceived relief in the alcohol, but not placebo, condition. However, expectancy specifically related to reduction in pain sensitivity (AE VAS 2) was not associated with relief. Additionally, changes in pain threshold and intensity were not significantly correlated with perceived relief. Taken together, results suggest expectancy that alcohol provides pain relief is an important determinant of its negative reinforcing effects. Future studies should investigate challenging these expectancies as a means of reducing alcohol-related risk in people with pain. (PsycInfo Database Record (c) 2024 APA, all rights reserved).

尽管实验室研究表明,酒精可以降低疼痛强度并提高疼痛阈值,但这些影响可能并不能完全解释饮酒后的疼痛缓解。在这项研究中,我们测试了酒精镇痛(EAA)作为口服酒精刺激后主观疼痛缓解的调节因子的预期值,用于患有和不患有慢性口腔面部疼痛的个体。社交饮酒者(N=48;19名慢性疼痛患者;29名无疼痛对照者)完成了两次测试:酒精给药(BrAC:0.08g/dL)和安慰剂。使用EAA问卷和两个100 mm视觉模拟量表(VAS)评估酒精预期(AE),评估酒精提供疼痛缓解(AE VAS 1)或降低疼痛敏感性(AE VAS 2)的信念强度。参与者完成了定量感觉测试(QST),包括对咬肌插入施加压力。收集疼痛阈值(lbf;三次重复)和疼痛强度(4、5和6 lbf;每次重复三次;100 mm VAS)。每次刺激后,参与者对因饮用研究饮料而感知到的疼痛缓解进行评分(0-100 VAS)。较高的EAA和AE VAS 1评分与更强的酒精缓解相关,但与安慰剂无关。然而,与疼痛敏感性降低特别相关的预期(AE VAS 2)与缓解无关。此外,疼痛阈值和强度的变化与感知缓解没有显著相关性。总之,研究结果表明,期望酒精能缓解疼痛是其负面强化作用的重要决定因素。未来的研究应该调查挑战这些预期,作为降低疼痛患者与酒精相关风险的一种手段。(PsycInfo数据库记录(c)2023 APA,保留所有权利)。
{"title":"Expectancy of alcohol analgesia moderates perception of pain relief following acute alcohol intake.","authors":"Casey Alexander, Nicholas J Bush, John K Neubert, Michael Robinson, Jeff Boissoneault","doi":"10.1037/pha0000664","DOIUrl":"10.1037/pha0000664","url":null,"abstract":"<p><p>Although laboratory studies indicate alcohol reduces pain intensity and increases pain threshold, these effects likely do not completely explain perceived pain relief from alcohol intake. In this study, we tested expectancy of alcohol analgesia (EAA) as a moderator of subjective pain relief following oral alcohol challenge in individuals with and without chronic orofacial pain. Social drinkers (<i>N</i> = 48; 19 chronic pain; 29 pain-free controls) completed two testing sessions: alcohol administration (BrAC: 0.08 g/dL) and placebo. Alcohol expectancy (AE) was assessed using the EAA questionnaire and two 100-mm Visual Analogue Scales (VASs) regarding strength of belief that alcohol provides pain relief (AE VAS 1) or reduces pain sensitivity (AE VAS 2). Participants completed quantitative sensory testing (QST) involving application of pressure to the masseter insertion. Pain threshold (lbf; three repetitions) and pain intensity (4, 5, and 6 lbf; three repetitions each; 100-mm VAS) were collected. After each stimulus, participants rated perceived pain relief due to consumption of the study beverage (0-100 VAS). Higher EAA and AE VAS 1 ratings were associated with stronger perceived relief in the alcohol, but not placebo, condition. However, expectancy specifically related to reduction in pain sensitivity (AE VAS 2) was not associated with relief. Additionally, changes in pain threshold and intensity were not significantly correlated with perceived relief. Taken together, results suggest expectancy that alcohol provides pain relief is an important determinant of its negative reinforcing effects. Future studies should investigate challenging these expectancies as a means of reducing alcohol-related risk in people with pain. (PsycInfo Database Record (c) 2024 APA, all rights reserved).</p>","PeriodicalId":12089,"journal":{"name":"Experimental and clinical psychopharmacology","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10749982/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9833553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating the indirect roles of anxiety and depressive symptoms in the relations between negative emotional reactivity to racial/ethnic stress and cigarette smoking among Hispanic adults who smoke. 评估焦虑和抑郁症状在吸烟的西班牙裔成年人对种族/民族压力的负面情绪反应与吸烟之间关系中的间接作用。
IF 2.3 3区 医学 Q2 Medicine Pub Date : 2024-03-07 DOI: 10.1037/pha0000708
Michael J Zvolensky, Justin M Shepherd, Salma Argueta, Andre Bizier, Bryce K Clausen, Julia D Buckner, Marcel A de Dios, Miguel Ángel Cano

There has been increased recognition that Hispanic/Latinx (hereinafter Hispanic) persons are a tobacco disparities group in the United States. Although some past work has found greater exposure to racial/ethnic discrimination is associated with indices of smoking among Hispanic persons, research has not explored the degree of negative emotional reactivity to racial/ethnic stress in terms of smoking processes. The present cross-sectional study served to evaluate the indirect effects of depressive and anxiety symptoms in terms of relations between racial/ethnic stress reactivity and cigarette dependence, severity of problems when trying to quit, and perceived barriers for quitting among Hispanic persons who smoke in the United States. Participants included 329 Hispanic adults who smoked cigarettes daily (Mage = 35.5 years; SD = 8.67; 37.4% female). Results indicated that depressive symptoms exerted a statistically significant indirect effect in the association between negative emotional reactivity to racial/ethnic stress and cigarette dependence and severity of problems when trying to quit, whereas anxiety symptoms maintained an indirect effect for perceived barriers for smoking cessation. The current findings help characterize the intricacies by which negative emotional reactivity to racial/ethnic stress is related to smoking behavior and beliefs among Hispanic persons who smoke. (PsycInfo Database Record (c) 2024 APA, all rights reserved).

越来越多的人认识到,西班牙裔/拉丁裔(以下简称西班牙裔)是美国的一个烟草不平等群体。尽管过去的一些研究发现,拉美裔美国人更容易受到种族/民族歧视,这与他们的吸烟指数有关,但还没有研究从吸烟过程的角度探讨他们对种族/民族压力的负面情绪反应程度。本横断面研究旨在评估抑郁和焦虑症状对美国吸烟的拉美裔人群中种族/民族压力反应性与香烟依赖性、戒烟问题的严重程度以及戒烟障碍之间关系的间接影响。研究对象包括 329 名每天吸烟的西班牙裔成年人(年龄:35.5 岁;标准差:8.67;女性:37.4%)。研究结果表明,抑郁症状对种族/民族压力的负面情绪反应与香烟依赖和戒烟问题严重程度之间的关联具有统计学意义上的间接影响,而焦虑症状对戒烟障碍的感知具有间接影响。目前的研究结果有助于说明种族/民族压力的负面情绪反应与吸烟的西班牙裔人士的吸烟行为和信念之间的复杂关系。(PsycInfo Database Record (c) 2024 APA,保留所有权利)。
{"title":"Evaluating the indirect roles of anxiety and depressive symptoms in the relations between negative emotional reactivity to racial/ethnic stress and cigarette smoking among Hispanic adults who smoke.","authors":"Michael J Zvolensky, Justin M Shepherd, Salma Argueta, Andre Bizier, Bryce K Clausen, Julia D Buckner, Marcel A de Dios, Miguel Ángel Cano","doi":"10.1037/pha0000708","DOIUrl":"https://doi.org/10.1037/pha0000708","url":null,"abstract":"<p><p>There has been increased recognition that Hispanic/Latinx (hereinafter Hispanic) persons are a tobacco disparities group in the United States. Although some past work has found greater exposure to racial/ethnic discrimination is associated with indices of smoking among Hispanic persons, research has not explored the degree of negative emotional reactivity to racial/ethnic stress in terms of smoking processes. The present cross-sectional study served to evaluate the indirect effects of depressive and anxiety symptoms in terms of relations between racial/ethnic stress reactivity and cigarette dependence, severity of problems when trying to quit, and perceived barriers for quitting among Hispanic persons who smoke in the United States. Participants included 329 Hispanic adults who smoked cigarettes daily (<i>M</i><sub>age</sub> = 35.5 years; <i>SD</i> = 8.67; 37.4% female). Results indicated that depressive symptoms exerted a statistically significant indirect effect in the association between negative emotional reactivity to racial/ethnic stress and cigarette dependence and severity of problems when trying to quit, whereas anxiety symptoms maintained an indirect effect for perceived barriers for smoking cessation. The current findings help characterize the intricacies by which negative emotional reactivity to racial/ethnic stress is related to smoking behavior and beliefs among Hispanic persons who smoke. (PsycInfo Database Record (c) 2024 APA, all rights reserved).</p>","PeriodicalId":12089,"journal":{"name":"Experimental and clinical psychopharmacology","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140059036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Examination of the effects of cannabidiol on menstrual-related symptoms. 研究大麻二酚对月经相关症状的影响。
IF 2.3 3区 医学 Q2 Medicine Pub Date : 2024-03-07 DOI: 10.1037/pha0000709
Morgan L Ferretti, Taylor B Stanley, Erica N Peters, Marcel O Bonn-Miller, Jessica G Irons

Some individuals attempt to alleviate menstrual-related symptoms (MRS) by using cannabis and report having expectations that cannabis can improve MRS; however, no study has examined the effect of cannabinoids on MRS. The present study is a pre-post, randomized, open-label trial that aimed to examine the effects of oral cannabidiol (CBD) isolate for alleviating MRS. Participants were assigned randomly to one of two open-label dosing groups of CBD softgels (160 mg twice a day, BID, n = 17; 320 mg BID, n = 16) and completed a 1-month baseline period. Following baseline, participants were instructed to consume CBD starting the first day they believed they experienced symptoms each month and to take their assigned dose daily for 5 consecutive days for three CBD-consumption months. We examined differences in MRS and related outcomes between baseline and 3 months of CBD consumption. Results revealed reductions (in both dosing groups) in MRS, irritability, anxiety, global impression of change, stress, and subjective severity scores when comparing baseline to all 3 months of CBD consumption. Depression scores did not change in either dosing group. Findings suggest that CBD may have the potential for managing MRS. Importantly, changes in symptoms appeared in the first month of CBD consumption and persisted over the 3 consumption months. Further research is warranted comparing the effects of CBD to placebo (a limitation of the study) and examining the potential to optimize CBD consumption for reducing MRS (e.g., combining CBD with terpenes; varying routes and timing of administration). (PsycInfo Database Record (c) 2024 APA, all rights reserved).

一些人试图通过使用大麻来缓解月经相关症状(MRS),并表示期望大麻可以改善 MRS;然而,还没有研究探讨过大麻素对 MRS 的影响。本研究是一项前后、随机、开放标签试验,旨在考察口服大麻二酚(CBD)分离物对缓解 MRS 的效果。参与者被随机分配到两个开放标签的大麻二酚软胶囊剂量组之一(160 毫克,一天两次,BID,n = 17;320 毫克,BID,n = 16),并完成为期 1 个月的基线期。基线期结束后,参与者被要求从每月他们认为出现症状的第一天开始服用 CBD,并在服用 CBD 的三个月内连续 5 天每天服用指定剂量。我们研究了基线与服用 CBD 3 个月之间 MRS 和相关结果的差异。结果显示,将基线值与服用 CBD 3 个月后的结果进行比较,MRS、烦躁、焦虑、总体变化印象、压力和主观严重性评分均有所下降(两组均为剂量组)。两个剂量组的抑郁评分均无变化。研究结果表明,CBD 有可能控制 MRS。重要的是,症状的变化出现在服用 CBD 的第一个月,并持续了 3 个月。有必要进一步研究将 CBD 的效果与安慰剂进行比较(这是本研究的局限性之一),并研究如何优化 CBD 的使用,以减少 MRS(例如,将 CBD 与萜类化合物结合使用;改变给药途径和给药时间)。(PsycInfo Database Record (c) 2024 APA,保留所有权利)。
{"title":"Examination of the effects of cannabidiol on menstrual-related symptoms.","authors":"Morgan L Ferretti, Taylor B Stanley, Erica N Peters, Marcel O Bonn-Miller, Jessica G Irons","doi":"10.1037/pha0000709","DOIUrl":"https://doi.org/10.1037/pha0000709","url":null,"abstract":"<p><p>Some individuals attempt to alleviate menstrual-related symptoms (MRS) by using cannabis and report having expectations that cannabis can improve MRS; however, no study has examined the effect of cannabinoids on MRS. The present study is a pre-post, randomized, open-label trial that aimed to examine the effects of oral cannabidiol (CBD) isolate for alleviating MRS. Participants were assigned randomly to one of two open-label dosing groups of CBD softgels (160 mg twice a day, BID, <i>n</i> = 17; 320 mg BID, <i>n</i> = 16) and completed a 1-month baseline period. Following baseline, participants were instructed to consume CBD starting the first day they believed they experienced symptoms each month and to take their assigned dose daily for 5 consecutive days for three CBD-consumption months. We examined differences in MRS and related outcomes between baseline and 3 months of CBD consumption. Results revealed reductions (in both dosing groups) in MRS, irritability, anxiety, global impression of change, stress, and subjective severity scores when comparing baseline to all 3 months of CBD consumption. Depression scores did not change in either dosing group. Findings suggest that CBD may have the potential for managing MRS. Importantly, changes in symptoms appeared in the first month of CBD consumption and persisted over the 3 consumption months. Further research is warranted comparing the effects of CBD to placebo (a limitation of the study) and examining the potential to optimize CBD consumption for reducing MRS (e.g., combining CBD with terpenes; varying routes and timing of administration). (PsycInfo Database Record (c) 2024 APA, all rights reserved).</p>","PeriodicalId":12089,"journal":{"name":"Experimental and clinical psychopharmacology","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140059037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A cross-sectional examination of race, gender, and intersectionality on protective behavioral strategies and alcohol outcomes among Black and White college students. 对黑人和白人大学生的种族、性别和交叉性对保护行为策略和酒精结果的影响进行横截面研究。
IF 2.3 3区 医学 Q2 Medicine Pub Date : 2024-03-07 DOI: 10.1037/pha0000712
Rachel Ayala Guzman, Olivia L Bolts, Jennifer L Shipley, Megan Strowger, Mark A Prince, Abby L Braitman

College students consistently report problematic alcohol use (e.g., excessive drinking). Protective behavioral strategies (PBS) are behaviors for reducing alcohol use and/or problems and are negatively associated with alcohol misuse among college students. Studies suggest PBS are used more often and/or more effectively by female individuals. Additionally, examinations specifically between Black and White students have yielded mixed findings and are typically underpowered. Scant studies have investigated the intersectionality between race and gender or examined perceived effectiveness of PBS use related to alcohol outcomes. The current cross-sectional study examined if (a) race, (b) gender, and (c) their interaction moderate the associations between perceived effectiveness of PBS use on PBS use (a path) and between PBS use on alcohol outcomes (i.e., alcohol quantity, peak drinks, and problems; b path). A sample size of N = 528 college drinkers ages 18-24 years old (Mage = 19.85; 52.5%, Black, 40.3% White) completed an online survey and were used for analyses. A series of moderated mediation models were conducted. Race did not moderate the a or b paths. The positive association for the a path as well as the indirect effect of PBS perceived effectiveness on lower alcohol outcomes through PBS use were stronger for female students than male students. The intersectionality examination indicated a stronger association between more PBS use and lower consumption, specifically for White male students, and lower problems for Black female students. More attention is needed toward considering intersectionality when identifying at-risk groups and tailoring alcohol intervention efforts. (PsycInfo Database Record (c) 2024 APA, all rights reserved).

大学生经常报告有饮酒问题(如过度饮酒)。保护性行为策略(PBS)是减少酒精使用和/或问题的行为,与大学生的酒精滥用呈负相关。研究表明,女性更经常和/或更有效地使用 PBS。此外,专门针对黑人和白人学生的研究结果也不尽相同,而且通常研究力量不足。很少有研究对种族和性别之间的交叉性进行调查,也很少有研究对与酒精结果相关的 PBS 使用效果进行调查。目前的横断面研究考察了(a)种族、(b)性别和(c)它们之间的相互作用是否会缓和PBS使用的感知有效性与PBS使用之间的关联(a路径)以及PBS使用与酒精结果(即酒精量、最高饮酒量和问题;b路径)之间的关联。完成在线调查并用于分析的样本量为 N = 528 名 18-24 岁的大学生饮酒者(年龄 = 19.85;52.5% 为黑人,40.3% 为白人)。我们建立了一系列调节中介模型。种族并没有调节 a 或 b 路径。与男生相比,女生在 a 路径上的正相关性以及通过使用公共健康教育系统对降低酗酒结果的间接影响更强。交叉性研究表明,使用更多的公共健康教育计划与降低饮酒量之间的关联性更强,尤其是对白人男生而言,而对黑人女生而言,问题更少。在识别高危人群和调整酒精干预措施时,需要更多地关注交叉性。(PsycInfo Database Record (c) 2024 APA, 版权所有)。
{"title":"A cross-sectional examination of race, gender, and intersectionality on protective behavioral strategies and alcohol outcomes among Black and White college students.","authors":"Rachel Ayala Guzman, Olivia L Bolts, Jennifer L Shipley, Megan Strowger, Mark A Prince, Abby L Braitman","doi":"10.1037/pha0000712","DOIUrl":"10.1037/pha0000712","url":null,"abstract":"<p><p>College students consistently report problematic alcohol use (e.g., excessive drinking). Protective behavioral strategies (PBS) are behaviors for reducing alcohol use and/or problems and are negatively associated with alcohol misuse among college students. Studies suggest PBS are used more often and/or more effectively by female individuals. Additionally, examinations specifically between Black and White students have yielded mixed findings and are typically underpowered. Scant studies have investigated the intersectionality between race and gender or examined perceived effectiveness of PBS use related to alcohol outcomes. The current cross-sectional study examined if (a) race, (b) gender, and (c) their interaction moderate the associations between perceived effectiveness of PBS use on PBS use (<i>a</i> path) and between PBS use on alcohol outcomes (i.e., alcohol quantity, peak drinks, and problems; <i>b</i> path). A sample size of <i>N</i> = 528 college drinkers ages 18-24 years old (<i>M</i><sub>age</sub> = 19.85; 52.5%, Black, 40.3% White) completed an online survey and were used for analyses. A series of moderated mediation models were conducted. Race did not moderate the <i>a</i> or <i>b</i> paths. The positive association for the a path as well as the indirect effect of PBS perceived effectiveness on lower alcohol outcomes through PBS use were stronger for female students than male students. The intersectionality examination indicated a stronger association between more PBS use and lower consumption, specifically for White male students, and lower problems for Black female students. More attention is needed toward considering intersectionality when identifying at-risk groups and tailoring alcohol intervention efforts. (PsycInfo Database Record (c) 2024 APA, all rights reserved).</p>","PeriodicalId":12089,"journal":{"name":"Experimental and clinical psychopharmacology","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140059034","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Supplemental Material for Initial Evidence of the Acute Effect of Electronic Nicotine Delivery System Use on Energy Intake 关于使用电子尼古丁输送系统对能量摄入的急性影响的初步证据的补充材料
IF 2.3 3区 医学 Q2 Medicine Pub Date : 2024-02-12 DOI: 10.1037/pha0000710.supp
{"title":"Supplemental Material for Initial Evidence of the Acute Effect of Electronic Nicotine Delivery System Use on Energy Intake","authors":"","doi":"10.1037/pha0000710.supp","DOIUrl":"https://doi.org/10.1037/pha0000710.supp","url":null,"abstract":"","PeriodicalId":12089,"journal":{"name":"Experimental and clinical psychopharmacology","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139843209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Supplemental Material for Initial Evidence of the Acute Effect of Electronic Nicotine Delivery System Use on Energy Intake 关于使用电子尼古丁输送系统对能量摄入的急性影响的初步证据的补充材料
IF 2.3 3区 医学 Q2 Medicine Pub Date : 2024-02-12 DOI: 10.1037/pha0000710.supp
{"title":"Supplemental Material for Initial Evidence of the Acute Effect of Electronic Nicotine Delivery System Use on Energy Intake","authors":"","doi":"10.1037/pha0000710.supp","DOIUrl":"https://doi.org/10.1037/pha0000710.supp","url":null,"abstract":"","PeriodicalId":12089,"journal":{"name":"Experimental and clinical psychopharmacology","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139783363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current suicide risk, but not lifetime history of attempted suicide, predicts treatment response to low-dose ketamine infusion: Post Hoc analysis of adjunctive ketamine study of Taiwanese patients with treatment-resistant depression. 目前的自杀风险(而非终生自杀未遂史)可预测低剂量氯胺酮输注的治疗反应:对台湾难治性抑郁症患者进行的氯胺酮辅助治疗研究的事后分析。
IF 2.3 3区 医学 Q2 Medicine Pub Date : 2024-02-01 Epub Date: 2023-05-18 DOI: 10.1037/pha0000658
Wei-Chen Lin, Tung-Ping Su, Cheng-Ta Li, Shih-Jen Tsai, Pei-Chi Tu, Ya-Mei Bai, Mu-Hong Chen

Whether current suicide risk or a history of attempted suicide is related to the antidepressant effect of a low-dose ketamine infusion remains unclear. In total, 47 patients with treatment-resistant depression (TRD), including 32 with low current suicide risk and 15 with moderate or high current suicide risk, were randomized to groups receiving a low-dose ketamine infusion of either 0.2 or 0.5 mg/kg. Among the patients, 21 had a lifetime history of attempted suicide. Suicide risk was assessed based on the Suicidal scale of the Mini-International Neuropsychiatric Interview. The 17-item Hamilton Depression Rating Scale (HDRS) was used to measure depressive symptoms at baseline, at 40 and 240 min after infusion, and sequentially on Days 2-7 and 14 after ketamine infusion. Generalized estimating equation models indicated that the time effects of both 0.5 and 0.2 mg/kg ketamine infusions were significant during the study period. The models also indicated that current suicide risk (p = .037) but not lifetime history of attempted suicide (p = .184) was related to the trajectory of total HDRS scores. Patients with moderate-to-high current suicide risk benefited more from the low-dose ketamine infusion compared with those with the low current suicide risk. Patients with TRD having moderate or high current suicide risk may be prioritized to receive a low-dose ketamine infusion, which may aid suicide prevention. (PsycInfo Database Record (c) 2024 APA, all rights reserved).

目前的自杀风险或自杀未遂史是否与低剂量氯胺酮输注的抗抑郁效果有关仍不清楚。研究人员随机将47名难治性抑郁症(TRD)患者分为接受0.2或0.5毫克/千克低剂量氯胺酮输注的组别,其中包括32名当前自杀风险较低的患者和15名当前自杀风险中等或较高的患者。在这些患者中,有21人一生中有过自杀未遂的经历。自杀风险根据迷你国际神经精神病学访谈的自杀量表进行评估。17项汉密尔顿抑郁量表(HDRS)用于测量基线、输注后40分钟和240分钟以及输注氯胺酮后第2-7天和第14天的抑郁症状。广义估计方程模型显示,在研究期间,0.5和0.2毫克/千克氯胺酮输注的时间效应都很显著。这些模型还表明,当前自杀风险(p = 0.037)与 HDRS 总分的变化轨迹有关,而与终生自杀未遂史(p = 0.184)无关。与当前自杀风险较低的患者相比,当前自杀风险中度至高度的患者从低剂量氯胺酮输注中获益更多。具有中度或高度自杀风险的TRD患者可优先接受低剂量氯胺酮输注,这可能有助于预防自杀。(PsycInfo Database Record (c) 2024 APA,版权所有)。
{"title":"Current suicide risk, but not lifetime history of attempted suicide, predicts treatment response to low-dose ketamine infusion: Post Hoc analysis of adjunctive ketamine study of Taiwanese patients with treatment-resistant depression.","authors":"Wei-Chen Lin, Tung-Ping Su, Cheng-Ta Li, Shih-Jen Tsai, Pei-Chi Tu, Ya-Mei Bai, Mu-Hong Chen","doi":"10.1037/pha0000658","DOIUrl":"10.1037/pha0000658","url":null,"abstract":"<p><p>Whether current suicide risk or a history of attempted suicide is related to the antidepressant effect of a low-dose ketamine infusion remains unclear. In total, 47 patients with treatment-resistant depression (TRD), including 32 with low current suicide risk and 15 with moderate or high current suicide risk, were randomized to groups receiving a low-dose ketamine infusion of either 0.2 or 0.5 mg/kg. Among the patients, 21 had a lifetime history of attempted suicide. Suicide risk was assessed based on the Suicidal scale of the Mini-International Neuropsychiatric Interview. The 17-item Hamilton Depression Rating Scale (HDRS) was used to measure depressive symptoms at baseline, at 40 and 240 min after infusion, and sequentially on Days 2-7 and 14 after ketamine infusion. Generalized estimating equation models indicated that the time effects of both 0.5 and 0.2 mg/kg ketamine infusions were significant during the study period. The models also indicated that current suicide risk (<i>p</i> = .037) but not lifetime history of attempted suicide (<i>p</i> = .184) was related to the trajectory of total HDRS scores. Patients with moderate-to-high current suicide risk benefited more from the low-dose ketamine infusion compared with those with the low current suicide risk. Patients with TRD having moderate or high current suicide risk may be prioritized to receive a low-dose ketamine infusion, which may aid suicide prevention. (PsycInfo Database Record (c) 2024 APA, all rights reserved).</p>","PeriodicalId":12089,"journal":{"name":"Experimental and clinical psychopharmacology","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9480052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of two novel treatments to promote smoking cessation: Savor and retrieval-extinction training pilot clinical trial findings. 开发两种促进戒烟的新型疗法:品味和检索-绝迹训练试点临床试验结果。
IF 2.4 3区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-02-01 Epub Date: 2023-03-13 DOI: 10.1037/pha0000644
Amanda M Palmer, Matthew J Carpenter, Nathaniel L Baker, Brett Froeliger, Madeline G Foster, Eric L Garland, Michael E Saladin, Benjamin A Toll

Despite decades of progress, cigarette smoking remains a significant contributor to disease burden. This effect is especially pronounced for specific priority populations, such as individuals who live in rural communities, in that the burden of tobacco smoking is greater among these groups than in urban areas and the general population. The present study aims to evaluate the feasibility and acceptability of two novel tobacco treatment interventions delivered through remote telehealth procedures to individuals who smoke in the state of South Carolina. Results also include exploratory analyses of smoking cessation outcomes. Study I evaluated savoring, a strategy based on mindfulness practices, alongside nicotine replacement therapy (NRT). Study II evaluated retrieval-extinction training (RET), a memory-modification paradigm alongside NRT. In Study I (savoring), recruitment and retention data showed high interest and engagement in the intervention components, and participants who received this intervention decreased cigarette smoking throughout the course of the treatment (ps < .05). In Study II (RET), results showed high interest and moderate engagement in treatment, although exploratory outcome analyses did not demonstrate significant treatment effects on smoking behaviors. Overall, both studies showed promise in generating interest among individuals who smoke in participating in remotely delivered, telehealth smoking cessation interventions with novel therapeutic targets. A brief savoring intervention appeared to have effects on cigarette smoking throughout treatment, whereas RET did not. Gaining insight from the present pilot study, future studies may improve the efficacy of these procedures and incorporate the treatment components into more robust available treatments. (PsycInfo Database Record (c) 2024 APA, all rights reserved).

尽管取得了几十年的进步,吸烟仍然是造成疾病负担的一个重要因素。这种影响对特定的重点人群尤为明显,例如生活在农村社区的人,因为这些人群的吸烟负担比城市地区和普通人群更大。本研究旨在评估通过远程医疗程序向南卡罗来纳州吸烟者提供两种新型烟草治疗干预措施的可行性和可接受性。研究结果还包括对戒烟效果的探索性分析。研究 I 评估了 "品味"(一种基于正念实践的策略)和尼古丁替代疗法(NRT)。研究二评估了检索-消减训练(RET),这是一种与尼古丁替代疗法(NRT)相结合的记忆修正范式。在研究 I(品味)中,招募和保留数据显示,参与者对干预内容的兴趣和参与度很高,接受干预的参与者在整个治疗过程中吸烟量有所下降(PS < .05)。研究二(RET)的结果显示,参与者对治疗有较高的兴趣和适度的参与,但探索性结果分析并未显示出治疗对吸烟行为的显著影响。总之,这两项研究都表明,吸烟者有兴趣参与具有新治疗目标的远程医疗戒烟干预。在整个治疗过程中,简短的品味干预似乎对吸烟有影响,而 RET 则没有。从目前的试点研究中获得启示后,未来的研究可能会提高这些程序的疗效,并将治疗内容纳入更强大的可用治疗中。(PsycInfo Database Record (c) 2024 APA,保留所有权利)。
{"title":"Development of two novel treatments to promote smoking cessation: Savor and retrieval-extinction training pilot clinical trial findings.","authors":"Amanda M Palmer, Matthew J Carpenter, Nathaniel L Baker, Brett Froeliger, Madeline G Foster, Eric L Garland, Michael E Saladin, Benjamin A Toll","doi":"10.1037/pha0000644","DOIUrl":"10.1037/pha0000644","url":null,"abstract":"<p><p>Despite decades of progress, cigarette smoking remains a significant contributor to disease burden. This effect is especially pronounced for specific priority populations, such as individuals who live in rural communities, in that the burden of tobacco smoking is greater among these groups than in urban areas and the general population. The present study aims to evaluate the feasibility and acceptability of two novel tobacco treatment interventions delivered through remote telehealth procedures to individuals who smoke in the state of South Carolina. Results also include exploratory analyses of smoking cessation outcomes. Study I evaluated savoring, a strategy based on mindfulness practices, alongside nicotine replacement therapy (NRT). Study II evaluated retrieval-extinction training (RET), a memory-modification paradigm alongside NRT. In Study I (savoring), recruitment and retention data showed high interest and engagement in the intervention components, and participants who received this intervention decreased cigarette smoking throughout the course of the treatment (<i>p</i>s < .05). In Study II (RET), results showed high interest and moderate engagement in treatment, although exploratory outcome analyses did not demonstrate significant treatment effects on smoking behaviors. Overall, both studies showed promise in generating interest among individuals who smoke in participating in remotely delivered, telehealth smoking cessation interventions with novel therapeutic targets. A brief savoring intervention appeared to have effects on cigarette smoking throughout treatment, whereas RET did not. Gaining insight from the present pilot study, future studies may improve the efficacy of these procedures and incorporate the treatment components into more robust available treatments. (PsycInfo Database Record (c) 2024 APA, all rights reserved).</p>","PeriodicalId":12089,"journal":{"name":"Experimental and clinical psychopharmacology","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497721/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10237225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alcohol demand in college students: The roles of athletic involvement and gender. 大学生的酒精需求:运动参与和性别的作用。
IF 2.3 3区 医学 Q2 Medicine Pub Date : 2024-02-01 Epub Date: 2023-10-12 DOI: 10.1037/pha0000681
Rebecca Kurnellas, Rose Marie Ward, Elizabeth Taylor, Margaret P Martinetti

College student-athletes represent a high-risk group for heavy alcohol consumption and negative alcohol-related consequences. Although college drinking correlates with access to low-cost alcohol, no study has examined demand, or the relationship between price and consumption, in student-athletes. Furthermore, the prevalence of anxiety, depression, and drinking to cope motives in student-athletes suggest athlete-specific risks of alcohol consumption that have not yet been examined in conjunction with demand. Therefore, the present study examined gender differences in alcohol demand, alcohol consumption, and anxiety and depressive symptoms in student-athletes (n = 118) and nonathletes (n = 78) at three colleges/universities. Participants completed the Alcohol Purchase Task and measures of alcohol-related behaviors and mental health. Observed demand indices including intensity (i.e., consumption at zero price), Omax (i.e., maximum expenditure), Pmax (i.e., price associated with Omax), and breakpoint-1, or BP₁ (i.e., highest price of nonzero consumption) were calculated at the individual level. The rate of change in demand elasticity (i.e., decrease in consumption relative to price increases) was calculated at the group level. Overall, students reported lower alcohol consumption at higher alcohol prices, but men reported higher alcohol consumption and demand intensity than women, student-athletes reported higher Omax than nonathletes, and student-athletes reported lower depressive symptoms than nonathletes. These findings support reducing access to low-cost alcohol in college drinking environments as a harm-reduction strategy, particularly for high-risk student populations, such as men and those involved in athletics. (PsycInfo Database Record (c) 2024 APA, all rights reserved).

大学生运动员是重度饮酒和不良酒精相关后果的高危人群。尽管大学饮酒与获得低成本酒精有关,但没有研究调查学生运动员的需求或价格与消费之间的关系。此外,学生运动员中焦虑、抑郁和饮酒动机的普遍性表明,运动员饮酒的特定风险尚未与需求结合起来进行研究。因此,本研究调查了三所学院/大学的学生运动员(n=118)和非运动员(n=78)在饮酒、饮酒、焦虑和抑郁症状方面的性别差异。参与者完成了酒精购买任务以及酒精相关行为和心理健康的测量。观察到的需求指数,包括强度(即零价格下的消费)、Omax(即最大支出)、Pmax(即与Omax相关的价格)和临界点-1或BP₁ (即非零消费的最高价格)是在个人层面上计算的。需求弹性的变化率(即消费相对于价格上涨的下降)是在群体层面计算的。总体而言,学生报告的酒精消费量较低,酒精价格较高,但男性报告的酒精消耗量和需求强度高于女性,学生运动员报告的Omax高于非运动员,学生运动员的抑郁症状低于非运动员。这些发现支持减少在大学饮酒环境中获得低成本酒精的机会,以此作为一种减少伤害的策略,尤其是对高危学生群体,如男性和体育运动参与者。(PsycInfo数据库记录(c)2023 APA,保留所有权利)。
{"title":"Alcohol demand in college students: The roles of athletic involvement and gender.","authors":"Rebecca Kurnellas, Rose Marie Ward, Elizabeth Taylor, Margaret P Martinetti","doi":"10.1037/pha0000681","DOIUrl":"10.1037/pha0000681","url":null,"abstract":"<p><p>College student-athletes represent a high-risk group for heavy alcohol consumption and negative alcohol-related consequences. Although college drinking correlates with access to low-cost alcohol, no study has examined demand, or the relationship between price and consumption, in student-athletes. Furthermore, the prevalence of anxiety, depression, and drinking to cope motives in student-athletes suggest athlete-specific risks of alcohol consumption that have not yet been examined in conjunction with demand. Therefore, the present study examined gender differences in alcohol demand, alcohol consumption, and anxiety and depressive symptoms in student-athletes (<i>n</i> = 118) and nonathletes (<i>n</i> = 78) at three colleges/universities. Participants completed the Alcohol Purchase Task and measures of alcohol-related behaviors and mental health. Observed demand indices including intensity (i.e., consumption at zero price), <i>O</i><sub>max</sub> (i.e., maximum expenditure), <i>P</i><sub>max</sub> (i.e., price associated with <i>O</i><sub>max</sub>), and breakpoint-1, or BP₁ (i.e., highest price of nonzero consumption) were calculated at the individual level. The rate of change in demand elasticity (i.e., decrease in consumption relative to price increases) was calculated at the group level. Overall, students reported lower alcohol consumption at higher alcohol prices, but men reported higher alcohol consumption and demand intensity than women, student-athletes reported higher <i>O</i><sub>max</sub> than nonathletes, and student-athletes reported lower depressive symptoms than nonathletes. These findings support reducing access to low-cost alcohol in college drinking environments as a harm-reduction strategy, particularly for high-risk student populations, such as men and those involved in athletics. (PsycInfo Database Record (c) 2024 APA, all rights reserved).</p>","PeriodicalId":12089,"journal":{"name":"Experimental and clinical psychopharmacology","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41195878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Examining the validity of the addictions neuroclinical assessment domains in a crowdsourced sample of adults with current alcohol use. 在当前酗酒成年人的众包样本中检验成瘾神经临床评估领域的有效性。
IF 2.3 3区 医学 Q2 Medicine Pub Date : 2024-02-01 Epub Date: 2023-05-25 DOI: 10.1037/pha0000648
Victoria R Votaw, Cassandra L Boness, Elena R Stein, Ashley L Watts, Kenneth J Sher, Katie Witkiewitz

Several dimensional frameworks for characterizing heterogeneity in alcohol use disorder (AUD) have been proposed, including the Addictions Neuroclinical Assessment (ANA). The ANA is a framework for assessing individual variability within AUD across three domains corresponding to the proposed stages of the addiction cycle: reward (binge-intoxication stage), negative emotionality (withdrawal-negative affect stage), and cognitive control (preoccupation-anticipation stage). Recent work has evaluated the ANA's three-factor structure and construct validity, primarily in treatment-seekers with AUD. We extended this research by examining the factor structure, bias across alcohol use severity, longitudinal invariance, and concurrent and predictive validity of a novel assessment of the ANA domains in adults with past 12-month regular (10 + alcohol units/week) alcohol use. Participants recruited from Prolific (N = 732), a crowdsourced data collection platform, completed various self-report measures. A test-retest subsample (n = 234) completed these measures 30 days later. Split-half exploratory factor analysis and confirmatory factor analysis supported the three-factor structure of the ANA. The overall factor structure was invariant across 30 days. Concurrently and prospectively, ANA domains demonstrated convergent validity concerning theoretically aligned alcohol-related, psychological, and personality measures. However, there was evidence of poor discriminant validity, and several cognitive control and reward items demonstrated bias across alcohol use severity. Future research is needed to improve the measurement of ANA domains using multimodal indicators, examine longitudinal changes in domains and their relationship with alcohol use severity, characterize phenotypic subgroups based on relative levels of domains, and compare the utility of the ANA with other proposed frameworks for measuring AUD heterogeneity. (PsycInfo Database Record (c) 2024 APA, all rights reserved).

目前已提出了几种用于描述酒精使用障碍(AUD)异质性的维度框架,其中包括成瘾神经临床评估(ANA)。ANA 是一个框架,用于评估 AUD 在三个领域的个体差异性,这三个领域分别对应于所提出的成瘾周期阶段:奖赏(狂欢-中毒阶段)、负性情绪(戒断-负性情绪阶段)和认知控制(专注-预期阶段)。最近的研究对 ANA 的三因素结构和建构有效性进行了评估,主要是针对 AUD 的寻求治疗者。我们扩展了这一研究,对过去 12 个月经常饮酒(10 个酒精单位/周)的成年人进行了 ANA 领域的新评估,检验了其因子结构、不同饮酒严重程度的偏差、纵向不变性、并发和预测有效性。从众包数据收集平台 Prolific(N = 732)招募的参与者完成了各种自我报告测量。一个测试-重测子样本(n = 234)在 30 天后完成了这些测量。分半探索性因子分析和确认性因子分析支持 ANA 的三因子结构。总体因子结构在 30 天内保持不变。同时,ANA 的各个域在与酒精相关的理论、心理和人格测量方面表现出了前瞻性的趋同效度。但是,有证据表明其判别效度较差,而且几个认知控制和奖赏项目在不同的酒精使用严重程度下表现出偏差。未来的研究需要使用多模式指标改进 ANA 领域的测量,检查领域的纵向变化及其与酒精使用严重程度的关系,根据领域的相对水平描述表型亚组的特征,并比较 ANA 与其他建议的 AUD 异质性测量框架的效用。(PsycInfo Database Record (c) 2024 APA,保留所有权利)。
{"title":"Examining the validity of the addictions neuroclinical assessment domains in a crowdsourced sample of adults with current alcohol use.","authors":"Victoria R Votaw, Cassandra L Boness, Elena R Stein, Ashley L Watts, Kenneth J Sher, Katie Witkiewitz","doi":"10.1037/pha0000648","DOIUrl":"10.1037/pha0000648","url":null,"abstract":"<p><p>Several dimensional frameworks for characterizing heterogeneity in alcohol use disorder (AUD) have been proposed, including the Addictions Neuroclinical Assessment (ANA). The ANA is a framework for assessing individual variability within AUD across three domains corresponding to the proposed stages of the addiction cycle: reward (binge-intoxication stage), negative emotionality (withdrawal-negative affect stage), and cognitive control (preoccupation-anticipation stage). Recent work has evaluated the ANA's three-factor structure and construct validity, primarily in treatment-seekers with AUD. We extended this research by examining the factor structure, bias across alcohol use severity, longitudinal invariance, and concurrent and predictive validity of a novel assessment of the ANA domains in adults with past 12-month regular (10 + alcohol units/week) alcohol use. Participants recruited from Prolific (<i>N</i> = 732), a crowdsourced data collection platform, completed various self-report measures. A test-retest subsample (<i>n</i> = 234) completed these measures 30 days later. Split-half exploratory factor analysis and confirmatory factor analysis supported the three-factor structure of the ANA. The overall factor structure was invariant across 30 days. Concurrently and prospectively, ANA domains demonstrated convergent validity concerning theoretically aligned alcohol-related, psychological, and personality measures. However, there was evidence of poor discriminant validity, and several cognitive control and reward items demonstrated bias across alcohol use severity. Future research is needed to improve the measurement of ANA domains using multimodal indicators, examine longitudinal changes in domains and their relationship with alcohol use severity, characterize phenotypic subgroups based on relative levels of domains, and compare the utility of the ANA with other proposed frameworks for measuring AUD heterogeneity. (PsycInfo Database Record (c) 2024 APA, all rights reserved).</p>","PeriodicalId":12089,"journal":{"name":"Experimental and clinical psychopharmacology","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11088344/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9522375","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Experimental and clinical psychopharmacology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1